ClinicalTrialsFinder

Platinum-resistant Recurrent Ovarian Cancer Clinical Trials in Guangzhou, Guangdong

1 recruitingGuangzhou, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

Advanced Solid TumorPlatinum-resistant Recurrent Ovarian Cancer
Ascentage Pharma Group Inc.50 enrolled1 locationNCT06687070